General Theory of Inflammation. Patient Education Key to Microdose Therapy for Chronic Inflammation Control |Biomedgrid

Microdose therapy is patient self-administration of hydrocortisone with stress management to control chronic inflammation within inflammation disorders [1]. Using microdose therapy, patients require so little hydrocortisone that overdose effects are avoided. Using this plan, patients average ingesting less hydrocortisone to achieve superior symptom control than low dose, daily hydrocortisone achieves, hence the given name micro dose therapy. The chronic inflammation cause is the weakening hydrocortisone surge in the blood produced by an activated hypothalamic-pituitary-adrenal (HPA) axis. As it weakens, short-term, beneficial inflammation increasingly evolves into chronic inflammation.